Equanil and Salicylate - serum - a phase IV clinical study of FDA data
We study 1,544 people who take Equanil or have Salicylate - serum. No report of Salicylate - serum is found in people who take Equanil.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Equanil?
Equanil has active ingredients of meprobamate. It is often used in stress and anxiety. eHealthMe is studying from 1,242 Equanil users for its effectiveness, alternative drugs and more.
What is Salicylate - Serum?
Salicylate - serum is found to be associated with 1 drug and 6 conditions by eHealthMe.
Do you take Equanil and have Salicylate - serum?Check whether Salicylate - serum is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Salicylate - serum and when was it recovered:
Expand to all the drugs that have ingredients of meprobamate:
Alternative drugs to, pros and cons of Equanil:
- Equanil (1,242 reports)
Salicylate - serum treatments and more:
- Salicylate - serum (302 reports)
COVID vaccines that are related to Salicylate - serum:
- Salicylate - serum in Moderna COVID Vaccine
- Salicylate - serum in Pfizer BioNTech Covid Vaccine
- Salicylate - serum in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Salicylate - serum:
All the conditions that are associated with Salicylate - serum:
How the study uses the data?
The study uses data from the FDA. It is based on meprobamate (the active ingredients of Equanil) and Equanil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Olanzapine and Januvia drug interaction - a second ago
- Orencia and Sanctura drug interaction - 3 seconds ago
- Zyrtec and Hordeolum - 4 seconds ago
- Heparin and Lip Pain - 4 seconds ago
- Actos and Hyperglycemia - 5 seconds ago
- Flovent and Metapneumovirus Infection - 8 seconds ago
- Avastin and Ciclosporin drug interaction - 9 seconds ago
- Neupogen and Blood Alkaline Phosphatase Abnormal - 16 seconds ago
- Adempas and Byetta drug interaction - 20 seconds ago
- St. John'S Wort vs. Symbyax - 23 seconds ago